3rd Lifecycle Management for Combination Products Summit
June 2 - 4, 2020 - MA USHanson Wade
info@hansonwade.com
Phone:02031418700
The 3rd Lifecycle Management for Combination Products Summit is the only peer-led community that is bringing over 100+ senior leaders from drug-device teams including regulatory affairs, product development and quality together to share key opinions on how to maximize your combination products' lifespan and how to continue to deliver a quality drug-device product for your patients. Join the community to explore and discuss: How to handle and navigate the evolving regulatory landscape, especially EU MDR's commercial implications on combination products in Japan and APAC Design control and quality - how to collaborate with multiple teams for full oversight of LCM When should you start an LCM initiative? Challenges with drug-device products Assessing next gen combination products opportunities to extend your product lifespan Lifecycle management for drug-device combination products has stolen the spotlight amongst pharma, biotechs and device developers. That said, effectively integrating multiple project teams and defining a common LCM program can be challenging - but if you join us in June you will be given unparalleled access to key experts who can guide you on how to implement a robust LCM program to reap the significant benefits from the get-go.